Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy;Efficacité de la radiothérapie orbitaire combinée à la corticothérapie dans la prise en charge de l'ophtalmopathie basedowienne

Journal Medical Libanais

Volumn 58, Issue 2, 2010, Pages 86-90

  Nasr, Elie ^a   Khater, Sherine ^a   Nehme Nasr, Dolly ^a   Azoury, Fares ^a   Jambart, Selim ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE;

ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE DURATION; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; HUMAN; IRRADIATION; ORBITAL IRRADIATION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SELF EVALUATION; SYSTEMIC THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE; VISION; ADULT; FEMALE; RADIATION DOSE; RETROSPECTIVE STUDY;

ADULT; FEMALE; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; METHYLPREDNISOLONE; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 77954944910     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gorman CA, Garrity JA, Fatourechi V et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2001 ; 108 : 1523-34.
2. Gorman CA. Radiotherapy for Graves' ophthalmopathy : results at one year. Thyroid 2002 ; 12 (3) : 251-5.
3. Gorman CA, Garrity JA, Fatourechi V et al. The aftermath of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2002 ; 109 : 2100-7.
4. Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy : the GO-QOL. Br J Ophthalmol 1998 ; 82 : 773-9.
5. Terwee CB, Gerding MN, Dekker FW, Prummel MF, van der Pol JP, Wiersinga WM. Test-retest reliability of the GO-QOL : a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy. J Clin Epidemiol 1999 ; 52 : 875-84.
6. Terwee CB, Dekker FW, Mourits MP et al. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf) 2001 ; 54 : 391-8.
7. Prummel MF, Mourits MP, Blank L, Bergout A, Koornef L, Wiersinga WM. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993 ; 342 : 949-54.
8. Ng CM, Yuen HK, Choi KL et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study. Hong Kong Med J 2005 ; 11 (5) : 322-30.
9. Tsujino K, Hirota S, Hagiwara M et al. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 2000 ; 48 (3) : 857-64.
10. Zoumalan C, Cockerham K, Turbin R et al. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease. J Neuroophthalmol 2007 Sep ; 27 (3) : 205-14.
11. Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy. Endocrinol Metab Clin North Am 2000 ; 29 : 297-319.
12. Jaulerry C. The role of radiotherapy in Graves' ophthalmopathy. J Fr Ophtalmol 2004 Sep ; 27 (7) : 825-7.
13. Burch H, Wartofsky L. Graves' ophthalmopathy : current concepts regarding pathogenesis and management. Endocr Rev 1993 ; 14 : 747-93.
14. Cawood T, Moriarty P, O'Shea D. Recent developments in thyroid eye disease. BMJ 2004 ; 329 : 385-90.
15. Wiersinga WM, Prummel MF. Graves' ophthalmopathy : a rational approach to treatment. Trends Endocrinol Metab 2002 Sep; 13 (7): 280-7.
16. Wiersinga WM, Kahaly GJ : Graves' Orbitopathy : a Multidisciplinary Approach. Basel : Karger, 2007.